These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 20947480)

  • 21. Targeting cell spreading: a method of sensitizing metastatic tumor cells to TRAIL-induced apoptosis.
    Phipps LE; Hino S; Muschel RJ
    Mol Cancer Res; 2011 Mar; 9(3):249-58. PubMed ID: 21296861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic modulation of prostate cancer metastasis.
    Krishna SN; Bergan RC
    Future Med Chem; 2014 Feb; 6(2):223-39. PubMed ID: 24467245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research on the antimetastatic agents].
    Takeshima H
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():79-85. PubMed ID: 16201504
    [No Abstract]   [Full Text] [Related]  

  • 24. Adding Nanotechnology to the Metastasis Treatment Arsenal.
    Banerjee D; Cieslar-Pobuda A; Zhu GH; Wiechec E; Patra HK
    Trends Pharmacol Sci; 2019 Jun; 40(6):403-418. PubMed ID: 31076247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of heat-shock protein 90 on cancer metastasis.
    Tsutsumi S; Beebe K; Neckers L
    Future Oncol; 2009 Jun; 5(5):679-88. PubMed ID: 19519207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Utility of Chemotherapy in the Treatment of Metastatic Prostate Cancer.
    Gupta K; Elkon J; El-Bahesh E; Aragon-Ching JB
    Anticancer Agents Med Chem; 2016; 16(9):1166-71. PubMed ID: 24359499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimetastatic activities of heparins and modified heparins. Experimental evidence.
    Borsig L
    Thromb Res; 2010 Apr; 125 Suppl 2():S66-71. PubMed ID: 20434009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade.
    Singh BN; Singh HB; Singh A; Naqvi AH; Singh BR
    Cancer Metastasis Rev; 2014 Mar; 33(1):41-85. PubMed ID: 24390421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rethinking the metastatic cascade as a therapeutic target.
    Mina LA; Sledge GW
    Nat Rev Clin Oncol; 2011 Jun; 8(6):325-32. PubMed ID: 21502993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic targets for antimetastatic therapy.
    Hedley BD; Winquist E; Chambers AF
    Expert Opin Ther Targets; 2004 Dec; 8(6):527-36. PubMed ID: 15584860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The challenge of targeting metastasis.
    Fidler IJ; Kripke ML
    Cancer Metastasis Rev; 2015 Dec; 34(4):635-41. PubMed ID: 26328524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastasis-directed therapy for oligometastasis and beyond.
    Beckham TH; Yang TJ; Gomez D; Tsai CJ
    Br J Cancer; 2021 Jan; 124(1):136-141. PubMed ID: 33204024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
    Wong MS; Sidik SM; Mahmud R; Stanslas J
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):307-19. PubMed ID: 23534409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cadherins as novel targets for anti-cancer therapy.
    Blaschuk OW; Devemy E
    Eur J Pharmacol; 2009 Dec; 625(1-3):195-8. PubMed ID: 19836380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autophagy : Moving Benchside Promises to Patient Bedsides.
    Belaid A; Ndiaye PD; Filippakis H; Roux J; Röttinger É; Graba Y; Brest P; Hofman P; Mograbi B
    Curr Cancer Drug Targets; 2015; 15(8):684-702. PubMed ID: 26452384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current treatment of metastatic endometrial cancer.
    Temkin SM; Fleming G
    Cancer Control; 2009 Jan; 16(1):38-45. PubMed ID: 19078928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer metastasis: a search for therapeutic inhibition.
    Dimitroff CJ; Sharma A; Bernacki RJ
    Cancer Invest; 1998; 16(4):279-90. PubMed ID: 9589037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications.
    Lin Y; Xu J; Lan H
    J Hematol Oncol; 2019 Jul; 12(1):76. PubMed ID: 31300030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-(1-Ethyl-4-anisyl-imidazol-5-yl)-N-hydroxycinnamide - A new pleiotropic HDAC inhibitor targeting cancer cell signalling and cytoskeletal organisation.
    Mahal K; Kahlen P; Biersack B; Schobert R
    Exp Cell Res; 2015 Aug; 336(2):263-75. PubMed ID: 26101158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.